TOVA HECHT: Open Payments
NPI 1992163992 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,971 in 121 payments from 30 companies in 2025. Trend: 2023 $1,906 · 2024 $2,568 · 2025 $2,971
Food & beverage: $2,872Education: $100
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 14 | $466 |
| Janssen Biotech, Inc. | 10 | $375 |
| Eisai Inc. | 15 | $230 |
| Astellas Pharma US Inc | 5 | $200 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $148 |
| TAIHO ONCOLOGY, INC. | 10 | $147 |
| ABBVIE INC. | 1 | $138 |
| Novartis Pharmaceuticals Corporation | 4 | $107 |
| Merck Sharp & Dohme LLC | 4 | $100 |
| Gilead Sciences, Inc. | 5 | $95 |
Products named: Enhertu, Lenvima, RYBREVANT, LONSURF, AVYCAZ, Vyloy, TALVEY, Trodelvy.
Industry payments across NY — which companies pay providers there.
